Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients

Manuscript Preparation

Obesity Surgery · 1997 · 3.9K citations

Development, validity and responsiveness of the Clinical COPD Questionnaire.

Thys van der Molen, Brigitte W.M. Willemse, Siebrig Schokker et al. · Health and Quality of Life Outcomes · 2003 · 712 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases

Ronald P. Gladue, Laurie Tylaska, William H. Brissette et al. · Journal of Biological Chemistry · 2003 · 89 citations · Full text

Medicine, Immunology, Pharmacology +17

Blockade of chemokine signaling in patients with multiple sclerosis

Frauke Zipp, HP Hartung, Jan Hillert et al. · Neurology · 2006 · 83 citations

Life Sciences, Neurology, Pharmacology +17

Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases

Hilke Brühl, Klaus Wagner, H Kellner et al. · Clinical & Experimental Immunology · 2001 · 75 citations · Full text

Medicine, Cell Biology, Immunology +14